A recent research which used NHANES data from 2015 to 2018 discovered a strong correlation between the risk of osteoarthritis ...
Traditionally, high cholesterol was considered the primary risk factor for CVD. However, research now highlights the central ...
Rosuvastatin reduced LDL-cholesterol levels by 50% and high-sensitivity C-reactive protein by 37%. Compared with placebo, the combined primary end point was reduced in 44% (p < 0.00001), and total ...
Injections of semaglutide were associated with significant improvement in cognitive function in people living with HIV (PWH), ...
Metabolic syndrome (MetS) is characterized by abdominal obesity, dyslipidemia, hypertension and glucose intolerance, and is associated with an increased risk of developing cardiovascular disease ...
Blood samples were collected just before, immediately after, and three days after the event to measure high-sensitive C-reactive protein (hs-CRP) levels and immune cell counts. Low-grade ...
Methods Data regarding job history and high-sensitivity C reactive protein (hs-CRP) levels, as well as potential confounders, came from the Copenhagen Aging and Midlife Biobank. The participants’ self ...
high-sensitivity interleukin 6 (hs-IL-6), and high-sensitivity C-reactive protein (hsCRP) in a multicenter, phase 2, dose-finding randomized trial involving 281 patients with atherosclerotic ...
A new study published in the Journal of American Medical Association showed that the innovative small interfering RNA (siRNA) medication olpasiran (Amgen) can effectively reduce lipoprotein(a) ...